Stock Analysis on Net

Philip Morris International Inc. (NYSE:PM)

$24.99

Common-Size Income Statement
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

  • Get full access to the entire website from $10.42/mo, or

  • get 1-month access to Philip Morris International Inc. for $24.99.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Philip Morris International Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net revenues
Cost of sales
Gross profit
Marketing, administration and research costs
Impairment of goodwill
Operating income
Interest expense, net
Pension and other employee benefit costs
Earnings before income taxes
Provision for income taxes
Impairment related to the RBH equity investment
Equity investments and securities income (loss), net
Net earnings
Net earnings attributable to noncontrolling interests
Net earnings attributable to PMI

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


The quarterly financial data demonstrates several key trends observable in percentage terms relative to net revenues. Cost of sales fluctuates noticeably over the period, initially declining from around -33.58% to a low near -29.98% by early 2021, before gradually increasing and reaching a peak near -39.39% at the end of 2022. Subsequently, it shows a downward correction, settling around -32.15% by late 2025. This volatility in cost of sales impacts the gross profit margin, which correspondingly rises to a high above 70% in early 2021, then declines steadily to approximately 60.61% by the end of 2022, before improving again to around 67.85% by late 2025.

Operating Income and Related Expenses
Operating income as a percentage of net revenues shows variation, with a high near 45.41% in the first quarter of 2021 followed by a general decrease to lows around 28.62% to 31.93% through 2023 and an upward trend afterwards, reaching approximately 39.31% by the fourth quarter of 2025. Marketing, administration, and research costs remain relatively stable with fluctuations mostly between -24% and -31%, with a slight upward trend towards higher relative costs after 2022. Interest expense relative to net revenues exhibits inconsistency, with gradual increases peaking above -3.4% in the first half of 2024, a marked improvement to near -1.91% in late 2024, and subsequent oscillations.
Income Taxes and Earnings
The provision for income taxes varies considerably, initially near -8% but showing a notable drop to around -3.54% in early 2023, followed by sharp fluctuations, reaching values as low as -5% and as high as -11.28%, indicating irregular tax expense recognition patterns. Net earnings attributable to the company display a positive trend with periodic declines, including a significant negative value of approximately -5.97% observed in the first quarter of 2025. Despite this drop, net earnings recover strongly reaching above 33% of net revenues by late 2025.
Exceptional Items and Equity Investment Effects
Impairment of goodwill is recorded prominently at -7.42% in mid-2023 and a smaller charge near -0.4% later, affecting operating income for those periods. Additionally, an impairment linked to an equity investment appears as a severe one-time charge of approximately -23.86% in early 2025. Equity investments and securities income show high volatility, with positive spikes above 5% in late 2024 and a deep negative dip thereafter, indicating exposure to market or valuation fluctuations impacting other income significantly.

Overall, the data indicates that the company experiences periodic cost pressures that compress gross margins and operating income, partially offset by fluctuating but generally positive equity investment income. The volatility in tax provision and impairment charges suggests episodic impacts on earnings quality. Despite these variations, there is evidence of underlying profitability resilience, with net earnings relative to net revenues trending upward in the longer term after temporary setbacks.